TrialNature communications2023

EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial.

Jaron G de Wit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.